Biosimilar Adalimumab

Back to Products & Pipeline
Therapeuticdiscovery

Biosimilar Adalimumab

Originator: Humira (AbbVie)

Biosimilar program of Adalimumab (Humira), an anti-TNF-alpha monoclonal antibody used to treat a wide range of autoimmune conditions.

Biosimilar Adalimumab

Indications

  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Crohn's disease
  • Ulcerative colitis
  • Plaque psoriasis

Overview

Adalimumab (originator: Humira) is one of the world's best-selling biologics. IMGENEX India's biosimilar candidate is in early development, leveraging the company's proprietary CHO expression platform.

Contact us today to learn more about this product. You can also email us at info@imgenexindia.com.